Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Oct 1;98(7):1527–1532. doi: 10.1172/JCI118944

Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.

S Fujieda 1, J A Waschek 1, K Zhang 1, A Saxon 1
PMCID: PMC507583  PMID: 8833899

Abstract

Vasoactive intestinal peptide (VIP), a major neurotransmitter of peripheral nerves, has been suggested to function in host defense by regulating local human immune function. Indirect evidence has been marshaled that VIP can function as a switch factor for IgA in human Ig isotype recombination. In this study we directly tested the ability of VIP to function as a factor driving human B cells into IgA producing cells by assessing its ability to induce switch circular DNA representing direct mu to alpha switching. In addition we determined the generation of alpha germ-line transcripts and measured the level of IgA protein produced. Stimulation with VIP and CD40 mAb induced IgA production by human IgD+ B cells while VIP or CD40 alone failed to do so. Stimulation of purified IgD+ B cells with VIP plus CD40 mAb induced generation of switch circular DNA representing in vitro driven isotype switching from mu to alpha. CD40 mAb alone induced alpha germ-line transcripts but not IgA switch circles. Thus VIP, a neurogenic factor, can induce alpha-specific switching in CD40-activated human B cells and may thereby play an important role in directing the humoral immune response at mucosal surfaces.

Full Text

The Full Text of this article is available as a PDF (235.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraniuk J. N., Lundgren J. D., Okayama M., Mullol J., Merida M., Shelhamer J. H., Kaliner M. A. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest. 1990 Sep;86(3):825–831. doi: 10.1172/JCI114780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berisha H., Foda H., Sakakibara H., Trotz M., Pakbaz H., Said S. I. Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase. Am J Physiol. 1990 Aug;259(2 Pt 1):L151–L155. doi: 10.1152/ajplung.1990.259.2.L151. [DOI] [PubMed] [Google Scholar]
  3. Bertolini J. N., Bertolini J., Thean E., Benson E. M. Human low molecular weight B cell growth factor induces surface IgM+/A- B cells to express and secrete IgA. J Immunol. 1992 Sep 1;149(5):1771–1778. [PubMed] [Google Scholar]
  4. Boirivant M., Fais S., Annibale B., Agostini D., Delle Fave G., Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology. 1994 Mar;106(3):576–582. doi: 10.1016/0016-5085(94)90688-2. [DOI] [PubMed] [Google Scholar]
  5. Bondesson L., Norolind K., Lidén S., Gafvelin G., Theodorsson E., Mutt V. Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration. Acta Physiol Scand. 1991 Apr;141(4):477–481. doi: 10.1111/j.1748-1716.1991.tb09108.x. [DOI] [PubMed] [Google Scholar]
  6. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996 Jun;97(6):1288–1296. doi: 10.1016/s0091-6749(96)70197-5. [DOI] [PubMed] [Google Scholar]
  7. Bottaro A., Lansford R., Xu L., Zhang J., Rothman P., Alt F. W. S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J. 1994 Feb 1;13(3):665–674. doi: 10.1002/j.1460-2075.1994.tb06305.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chaen T., Watanabe N., Mogi G., Mori K., Takeyama M. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy. Ann Otol Rhinol Laryngol. 1993 Jan;102(1 Pt 1):16–21. doi: 10.1177/000348949310200104. [DOI] [PubMed] [Google Scholar]
  9. Chedeville A., Mirossay L., Chastre E., Hurbain-Kosmath I., Lopez M., Gespach C. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett. 1993 Mar 15;319(1-2):171–176. doi: 10.1016/0014-5793(93)80061-x. [DOI] [PubMed] [Google Scholar]
  10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  11. Chu C. C., Paul W. E., Max E. E. Quantitation of immunoglobulin mu-gamma 1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6978–6982. doi: 10.1073/pnas.89.15.6978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Danek A., O'Dorisio M. S., O'Dorisio T. M., George J. M. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol. 1983 Sep;131(3):1173–1177. [PubMed] [Google Scholar]
  13. Defrance T., Vanbervliet B., Brière F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992 Mar 1;175(3):671–682. doi: 10.1084/jem.175.3.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Esser C., Radbruch A. Immunoglobulin class switching: molecular and cellular analysis. Annu Rev Immunol. 1990;8:717–735. doi: 10.1146/annurev.iy.08.040190.003441. [DOI] [PubMed] [Google Scholar]
  15. Flanagan J. G., Lefranc M. P., Rabbitts T. H. Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. Cell. 1984 Mar;36(3):681–688. doi: 10.1016/0092-8674(84)90348-9. [DOI] [PubMed] [Google Scholar]
  16. Fujieda S., Zhang K., Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: switching to gamma 1, gamma 3, and gamma 4, but not gamma 2. J Immunol. 1995 Sep 1;155(5):2318–2328. [PubMed] [Google Scholar]
  17. Goetzl E. J., Adelman D. C., Sreedharan S. P. Neuroimmunology. Adv Immunol. 1990;48:161–190. doi: 10.1016/s0065-2776(08)60754-3. [DOI] [PubMed] [Google Scholar]
  18. Griffin B. E., Björck E., Bjursell G., Lindahl T. Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol. 1981 Oct;40(1):11–19. doi: 10.1128/jvi.40.1.11-19.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harriman G. R., Bradley A., Das S., Rogers-Fani P., Davis A. C. IgA class switch in I alpha exon-deficient mice. Role of germline transcription in class switch recombination. J Clin Invest. 1996 Jan 15;97(2):477–485. doi: 10.1172/JCI118438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Honjo T., Kataoka T. Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc Natl Acad Sci U S A. 1978 May;75(5):2140–2144. doi: 10.1073/pnas.75.5.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Islam K. B., Baskin B., Nilsson L., Hammarström L., Sideras P., Smith C. I. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol. 1994 Feb 1;152(3):1442–1452. [PubMed] [Google Scholar]
  22. Iwasato T., Arakawa H., Shimizu A., Honjo T., Yamagishi H. Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor beta and lipopolysaccharide. J Exp Med. 1992 Jun 1;175(6):1539–1546. doi: 10.1084/jem.175.6.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Iwasato T., Shimizu A., Honjo T., Yamagishi H. Circular DNA is excised by immunoglobulin class switch recombination. Cell. 1990 Jul 13;62(1):143–149. doi: 10.1016/0092-8674(90)90248-d. [DOI] [PubMed] [Google Scholar]
  24. Johnston J. A., Taub D. D., Lloyd A. R., Conlon K., Oppenheim J. J., Kevlin D. J. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol. 1994 Aug 15;153(4):1762–1768. [PubMed] [Google Scholar]
  25. Jung S., Rajewsky K., Radbruch A. Shutdown of class switch recombination by deletion of a switch region control element. Science. 1993 Feb 12;259(5097):984–987. doi: 10.1126/science.8438159. [DOI] [PubMed] [Google Scholar]
  26. Kilian M., Mestecky J., Russell M. W. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev. 1988 Jun;52(2):296–303. doi: 10.1128/mr.52.2.296-303.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kimata H., Fujimoto M. Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide. Blood. 1995 Apr 15;85(8):2098–2104. [PubMed] [Google Scholar]
  28. Kimata H., Fujimoto M. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur J Immunol. 1994 Sep;24(9):2262–2265. doi: 10.1002/eji.1830240950. [DOI] [PubMed] [Google Scholar]
  29. Kimata H., Yoshida A., Fujimoto M., Mikawa H. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol. 1993 May 15;150(10):4630–4640. [PubMed] [Google Scholar]
  30. Kitani A., Strober W. Differential regulation of C alpha 1 and C alpha 2 germ-line and mature mRNA transcripts in human peripheral blood B cells. J Immunol. 1994 Aug 15;153(4):1466–1477. [PubMed] [Google Scholar]
  31. Lebman D. A., Lee F. D., Coffman R. L. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol. 1990 Feb 1;144(3):952–959. [PubMed] [Google Scholar]
  32. Lorenz M., Jung S., Radbruch A. Switch transcripts in immunoglobulin class switching. Science. 1995 Mar 24;267(5205):1825–1828. doi: 10.1126/science.7892607. [DOI] [PubMed] [Google Scholar]
  33. Macy E., Kemeny M., Saxon A. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB J. 1988 Nov;2(14):3003–3009. doi: 10.1096/fasebj.2.14.3263291. [DOI] [PubMed] [Google Scholar]
  34. Matsuoka M., Yoshida K., Maeda T., Usuda S., Sakano H. Switch circular DNA formed in cytokine-treated mouse splenocytes: evidence for intramolecular DNA deletion in immunoglobulin class switching. Cell. 1990 Jul 13;62(1):135–142. doi: 10.1016/0092-8674(90)90247-c. [DOI] [PubMed] [Google Scholar]
  35. Mazanec M. B., Nedrud J. G., Kaetzel C. S., Lamm M. E. A three-tiered view of the role of IgA in mucosal defense. Immunol Today. 1993 Sep;14(9):430–435. doi: 10.1016/0167-5699(93)90245-G. [DOI] [PubMed] [Google Scholar]
  36. Mills F. C., Brooker J. S., Camerini-Otero R. D. Sequences of human immunoglobulin switch regions: implications for recombination and transcription. Nucleic Acids Res. 1990 Dec 25;18(24):7305–7316. doi: 10.1093/nar/18.24.7305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mosimann B. L., White M. V., Hohman R. J., Goldrich M. S., Kaulbach H. C., Kaliner M. A. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):95–104. doi: 10.1016/0091-6749(93)90043-f. [DOI] [PubMed] [Google Scholar]
  38. Nilsson L., Islam K. B., Olafsson O., Zalcberg I., Samakovlis C., Hammarström L., Smith C. I., Sideras P. Structure of TGF-beta 1-induced human immunoglobulin C alpha 1 and C alpha 2 germ-line transcripts. Int Immunol. 1991 Nov;3(11):1107–1115. doi: 10.1093/intimm/3.11.1107. [DOI] [PubMed] [Google Scholar]
  39. Ottaway C. A., Husband A. J. Central nervous system influences on lymphocyte migration. Brain Behav Immun. 1992 Jun;6(2):97–116. doi: 10.1016/0889-1591(92)90011-c. [DOI] [PubMed] [Google Scholar]
  40. Ottaway C. A. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J Exp Med. 1984 Oct 1;160(4):1054–1069. doi: 10.1084/jem.160.4.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ottaway C. A., Lay T. E., Greenberg G. R. High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J Neuroimmunol. 1990 Sep-Oct;29(1-3):149–155. doi: 10.1016/0165-5728(90)90157-i. [DOI] [PubMed] [Google Scholar]
  42. Ottaway C. A. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol Clin North Am. 1991 Sep;20(3):511–529. [PubMed] [Google Scholar]
  43. Ottaway C. A. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells. Immunology. 1987 Oct;62(2):291–297. [PMC free article] [PubMed] [Google Scholar]
  44. Rola-Pleszczynski M., Bolduc D., St-Pierre S. The effects of vasoactive intestinal peptide on human natural killer cell function. J Immunol. 1985 Oct;135(4):2569–2573. [PubMed] [Google Scholar]
  45. Said S. I. VIP as a modulator of lung inflammation and airway constriction. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S22–S24. doi: 10.1164/ajrccm/143.3_Pt_2.S22. [DOI] [PubMed] [Google Scholar]
  46. Said S. I. Vasoactive intestinal polypeptide (VIP): current status. Peptides. 1984 Mar-Apr;5(2):143–150. doi: 10.1016/0196-9781(84)90197-9. [DOI] [PubMed] [Google Scholar]
  47. Schulzke J. D., Riecken E. O., Fromm M. Distension-induced electrogenic Cl- secretion is mediated via VIP-ergic neurons in rat rectal colon. Am J Physiol. 1995 May;268(5 Pt 1):G725–G731. doi: 10.1152/ajpgi.1995.268.5.G725. [DOI] [PubMed] [Google Scholar]
  48. Stavnezer-Nordgren J., Sirlin S. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO J. 1986 Jan;5(1):95–102. doi: 10.1002/j.1460-2075.1986.tb04182.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ueyama T., Kozuki K., Houtani T., Ikeda M., Kitajiri M., Yamashita T., Kumazawa T., Nagatsu I., Sugimoto T. Immunolocalization of tyrosine hydroxylase and vasoactive intestinal polypeptide in nerve fibers innervating human palatine tonsil and paratonsillar glands. Neurosci Lett. 1990 Aug 14;116(1-2):70–74. doi: 10.1016/0304-3940(90)90388-p. [DOI] [PubMed] [Google Scholar]
  50. Waschek J. A., Bravo D. T., Richards M. L. High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells. Regul Pept. 1995 Dec 14;60(2-3):149–157. doi: 10.1016/0167-0115(95)00124-7. [DOI] [PubMed] [Google Scholar]
  51. Xin Z., Tang H., Ganea D. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J Neuroimmunol. 1994 Oct;54(1-2):59–68. doi: 10.1016/0165-5728(94)90231-3. [DOI] [PubMed] [Google Scholar]
  52. Xu L., Gorham B., Li S. C., Bottaro A., Alt F. W., Rothman P. Replacement of germ-line epsilon promoter by gene targeting alters control of immunoglobulin heavy chain class switching. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3705–3709. doi: 10.1073/pnas.90.8.3705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yancopoulos G. D., DePinho R. A., Zimmerman K. A., Lutzker S. G., Rosenberg N., Alt F. W. Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J. 1986 Dec 1;5(12):3259–3266. doi: 10.1002/j.1460-2075.1986.tb04637.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yoshida K., Matsuoka M., Usuda S., Mori A., Ishizaka K., Sakano H. Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7829–7833. doi: 10.1073/pnas.87.20.7829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yuan R., Casadevall A., Spira G., Scharff M. D. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol. 1995 Feb 15;154(4):1810–1816. [PubMed] [Google Scholar]
  56. Zhang J., Bottaro A., Li S., Stewart V., Alt F. W. A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J. 1993 Sep;12(9):3529–3537. doi: 10.1002/j.1460-2075.1993.tb06027.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zhang K., Clark E. A., Saxon A. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol. 1991 Mar 15;146(6):1836–1842. [PubMed] [Google Scholar]
  58. Zhang K., Mills F. C., Saxon A. Switch circles from IL-4-directed epsilon class switching from human B lymphocytes. Evidence for direct, sequential, and multiple step sequential switch from mu to epsilon Ig heavy chain gene. J Immunol. 1994 Apr 1;152(7):3427–3435. [PubMed] [Google Scholar]
  59. van Vlasselaer P., Punnonen J., de Vries J. E. Transforming growth factor-beta directs IgA switching in human B cells. J Immunol. 1992 Apr 1;148(7):2062–2067. [PubMed] [Google Scholar]
  60. von Schwedler U., Jäck H. M., Wabl M. Circular DNA is a product of the immunoglobulin class switch rearrangement. Nature. 1990 May 31;345(6274):452–456. doi: 10.1038/345452a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES